Willow Biosciences Inc. (WLLW.TO)

CAD 0.01

(0.0%)

Long Term Debt Summary of Willow Biosciences Inc.

  • Willow Biosciences Inc.'s latest annual long term debt in 2023 was 594 Thousand CAD , up 1756.25% from previous year.
  • Willow Biosciences Inc.'s latest quarterly long term debt in 2024 Q2 was 694 Thousand CAD , up 1.31% from previous quarter.
  • Willow Biosciences Inc. reported annual long term debt of 32 Thousand CAD in 2022, down -80.12% from previous year.
  • Willow Biosciences Inc. reported annual long term debt of 161 Thousand CAD in 2021, down -42.91% from previous year.
  • Willow Biosciences Inc. reported quarterly long term debt of 694 Thousand CAD for 2024 Q2, up 1.31% from previous quarter.
  • Willow Biosciences Inc. reported quarterly long term debt of 1.2 Million CAD for 2023 Q2, up 6588.89% from previous quarter.

Annual Long Term Debt Chart of Willow Biosciences Inc. (2023 - 1998)

Historical Annual Long Term Debt of Willow Biosciences Inc. (2023 - 1998)

Year Long Term Debt Long Term Debt Growth
2023 594 Thousand CAD 1756.25%
2022 32 Thousand CAD -80.12%
2021 161 Thousand CAD -42.91%
2020 282 Thousand CAD -37.39%
2019 450.4 Thousand CAD 0.0%
2018 - CAD 0.0%
2017 - CAD -100.0%
2016 1.23 Million CAD 0.0%
2015 - CAD 0.0%
2014 - CAD 0.0%
2013 - CAD 0.0%
2012 - CAD 0.0%
2011 - CAD 0.0%
2010 - CAD 0.0%
2009 - CAD 0.0%
2008 - CAD 0.0%
2007 - CAD 0.0%
2006 - CAD 0.0%
2005 - CAD 0.0%
2004 - CAD 0.0%
2003 - CAD 0.0%
2002 - CAD 0.0%
2001 - CAD 0.0%
2000 - CAD 0.0%
1999 - CAD 0.0%
1998 - CAD 0.0%

Peer Long Term Debt Comparison of Willow Biosciences Inc.

Name Long Term Debt Long Term Debt Difference
Aurora Cannabis Inc. 47.57 Million CAD 98.751%
Avicanna Inc. 95.36 Thousand CAD -522.89%
Avant Brands Inc. 1.74 Million CAD 65.882%
Cardiol Therapeutics Inc. 158.53 Thousand CAD -274.688%
Crescita Therapeutics Inc. 815 Thousand CAD 27.117%
Knight Therapeutics Inc. 44.01 Million CAD 98.65%
MediPharm Labs Corp. 69 Thousand CAD -760.87%
OrganiGram Holdings Inc. 79 Thousand CAD -651.899%
Canopy Growth Corporation 493.29 Million CAD 99.88%
Auxly Cannabis Group Inc. 81.38 Million CAD 99.27%